antimycotics for systemic use	is a	drug class
antimycotics for systemic use	treats	fungal infections
antimycotics for systemic use	includes	azoles
antimycotics for systemic use	includes	polyenes
antimycotics for systemic use	includes	echinocandins
antimycotics for systemic use	includes	allylamines
azoles	subclass of	antimycotics for systemic use
polyenes	subclass of	antimycotics for systemic use
echinocandins	subclass of	antimycotics for systemic use
allylamines	subclass of	antimycotics for systemic use
azoles	example	fluconazole
azoles	example	itraconazole
azoles	example	voriconazole
polyenes	example	amphotericin B
echinocandins	example	caspofungin
echinocandins	example	micafungin
allylamines	example	terbinafine
fluconazole	treats	candidiasis
itraconazole	treats	aspergillosis
voriconazole	treats	invasive fungal infections
amphotericin B	treats	systemic mycoses
caspofungin	treats	Candida infections
micafungin	treats	esophageal candidiasis
terbinafine	treats	dermatophyte infections
antimycotics for systemic use	mechanism	inhibits ergosterol synthesis
azoles	mechanism	inhibits CYP450
polyenes	mechanism	binds ergosterol
echinocandins	mechanism	inhibits glucan synthesis
allylamines	mechanism	inhibits squalene epoxidase
antimycotics for systemic use	side effects	liver toxicity
antimycotics for systemic use	side effects	kidney damage
antimycotics for systemic use	side effects	allergic reactions
azoles	side effects	QT prolongation
polyenes	side effects	nephrotoxicity
echinocandins	side effects	histamine release
allylamines	side effects	gastrointestinal distress
fluconazole	interacts with	warfarin
itraconazole	interacts with	cyclosporine
voriconazole	interacts with	rifampin
amphotericin B	interacts with	aminoglycosides
caspofungin	interacts with	cyclosporine
terbinafine	interacts with	caffeine
antimycotics for systemic use	contraindicated in	liver disease
antimycotics for systemic use	contraindicated in	pregnancy
azoles	contraindicated in	heart conditions
polyenes	contraindicated in	kidney impairment
echinocandins	contraindicated in	allergy
allylamines	contraindicated in	liver dysfunction
antimycotics for systemic use	administration route	intravenous
antimycotics for systemic use	administration route	oral
amphotericin B	administration route	IV only
echinocandins	administration route	IV only
terbinafine	administration route	oral
fluconazole	administration route	oral or IV
antimycotics for systemic use	monitoring parameter	liver function
antimycotics for systemic use	monitoring parameter	kidney function
antimycotics for systemic use	monitoring parameter	drug levels
voriconazole	monitoring parameter	visual changes
amphotericin B	monitoring parameter	electrolytes
antimycotics for systemic use	resistance mechanism	efflux pumps
antimycotics for systemic use	resistance mechanism	target modification
Candida	develops resistance to	azoles
Aspergillus	develops resistance to	echinocandins
dermatophytes	develops resistance to	allylamines
antimycotics for systemic use	spectrum	broad
antimycotics for systemic use	spectrum	narrow
amphotericin B	spectrum	broad
terbinafine	spectrum	narrow
antimycotics for systemic use	research focus	new formulations
antimycotics for systemic use	research focus	combination therapy
antimycotics for systemic use	research focus	resistance reversal
liposomal amphotericin B	reduces	toxicity
antimycotics for systemic use	cost factor	high
echinocandins	cost factor	highest
azoles	cost factor	moderate
antimycotics for systemic use	therapeutic index	narrow
antimycotics for systemic use	therapeutic index	wide
amphotericin B	therapeutic index	narrow
fluconazole	therapeutic index	wide
antimycotics for systemic use	duration	long-term
antimycotics for systemic use	duration	short-term
antimycotics for systemic use	prophylaxis use	immunocompromised
fluconazole	prophylaxis use	transplant patients
antimycotics for systemic use	pregnancy category	D
fluconazole	pregnancy category	D
terbinafine	pregnancy category	B
antimycotics for systemic use	pediatric use	caution
antimycotics for systemic use	geriatric use	caution
antimycotics for systemic use	black box warning	hepatotoxicity
voriconazole	black box warning	photosensitivity
antimycotics for systemic use	storage requirement	room temperature
amphotericin B	storage requirement	refrigeration
antimycotics for systemic use	brand examples	Diflucan
antimycotics for systemic use	brand examples	Vfend
antimycotics for systemic use	brand examples	Cancidas
antimycotics for systemic use	generic availability	yes
antimycotics for systemic use	FDA approval	required
antimycotics for systemic use	off-label use	common
antimycotics for systemic use	combination therapy	amphotericin B + flucytosine
antimycotics for systemic use	treatment duration	weeks to months
